Article Information
History
- January 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Juan Manuel Carreño1,
- Ariel Raskin1,
- Gagandeep Singh1,
- Johnstone Tcheou1,
- Hisaaki Kawabata1,
- Charles Gleason1,
- Komal Srivastava1,
- Vladimir Vigdorovich2,
- Nicholas Dambrauskas2,
- Sneh Lata Gupta3,4,
- Irene Gonzalez1,
- Jose Luis Martinez1,
- Stefan Slamanig1,
- D. Noah Sather2,5,
- Rama Raghunandan6,
- Ponthip Wirachwong7,
- Sant Muangnoicharoen8,
- Punnee Pitisuttithum8,
- Jens Wrammert3,4,
- Mehul S. Suthar3,4,9,
- Weina Sun1,
- Peter Palese1,10,
- Adolfo García-Sastre1,10,11,12,13,
- Viviana Simon1,10,11,13 and
- Florian Krammer1,13,*
- Rama Raghunandan, PhD PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA
- 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA
- 2Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle WA 98109 USA
- 3Centers for Childhood Infections and Vaccines, Children’s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329 USA
- 4Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30329 USA
- 5Department of Pediatrics, University of Washington, Seattle WA 98109 USA
- 6PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA
- 7The Government Pharmaceutical Organization, 1 Thanon Rama VI, Thung Phaya Thai, Ratchathewi, Bangkok 10400, Thailand
- 8Vaccine Trial Centre Faculty of Tropical Medicine, Mahidol, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand
- 9Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA
- 10Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA
- 11Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA
- 12The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA
- 13Department of Pathology, Molecular and Cell based Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA
- ↵*To whom correspondence should be addressed: florian.krammer{at}mssm.edu
Posted January 28, 2022.
The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines
